scholarly journals Model-informed drug development approach supporting approval of the 4-week (Q4W) dosing schedule for nivolumab (Opdivo) across multiple indications: a regulatory perspective

2019 ◽  
Vol 30 (4) ◽  
pp. 644-651 ◽  
Author(s):  
Y. Bi ◽  
J. Liu ◽  
B. Furmanski ◽  
H. Zhao ◽  
J. Yu ◽  
...  
Bioanalysis ◽  
2019 ◽  
Vol 11 (7) ◽  
pp. 607-610 ◽  
Author(s):  
Chongwoo Yu ◽  
E Dennis Bashaw

2012 ◽  
Vol 8 (3) ◽  
pp. 172-181 ◽  
Author(s):  
Alan Talevi ◽  
Carolina L. Bellera ◽  
Mauricio Di Ianni ◽  
Pablo R. Duchowicz ◽  
Luis E. Bruno-Blanch ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document